Bidirectional association between cardiovascular disease and hip fracture: a systematic review and meta-analysis

The aim of this study was to comprehensively analyze the bidirectional association between cardiovascular disease (CVD) and hip fracture (HF). We searched PubMed, EMBASE, Web of Sciences, Cochrane Library, ScienceDirect and China National Knowledge Infrastructure for relevant studies. The Newcastle-...

Full description

Saved in:
Bibliographic Details
Published inBMC cardiovascular disorders Vol. 25; no. 1; pp. 366 - 10
Main Authors Wu, Jinyi, Zhang, Yan, Wang, Junwen, Zhang, Qingsong, Jiang, Jun, Jiang, Qingwu, Zhou, Yibiao
Format Journal Article
LanguageEnglish
Published England BioMed Central 15.05.2025
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The aim of this study was to comprehensively analyze the bidirectional association between cardiovascular disease (CVD) and hip fracture (HF). We searched PubMed, EMBASE, Web of Sciences, Cochrane Library, ScienceDirect and China National Knowledge Infrastructure for relevant studies. The Newcastle-Ottawa scale was used to evaluate the risk of bias. We conducted random effects model for meta-analysis and subgroup analysis of different ethnic groups. Sensitivity analysis and publication bias of this study were also evaluated. This study followed the PRISMA and MOOSE guidelines for systematic reviews and meta-analyses. This research included 18 cohort studies and case-control studies with a total sample of 1,854,441 individuals. The results showed ischemic heart disease might increase the risk of HF (OR = 1.41, 95%CI[1.05, 1.89], I  = 96%). Stroke might be a risk factor for HF (OR = 2.23, 95%[1.18, 4.19], I  = 97%), and HF might likewise be a risk factor for Stroke ( OR = 2.22, 95% CI [1.81, 2.71], I  = 78%). Heart failure might increase the risk of HF (OR = 2.89, 95%CI [1.22, 6.85], I  = 91%), and HF might increase the risk of heart failure (OR = 2.74, 95%CI [1.27, 5.89], I  = 92%). Hypertension might increase the risk of HF (OR = 1.55, 95%CI[1.34, 1.8], I  = 87%), and HF might increase the risk of hypertension (OR = 3.75, 95%CI[3.3, 4.26], I  = 98%). Cerebrovascular disease (OR = 1.96, 95%CI[1.61, 2.4], I  = 79%) and diseases of arteries, arterioles, and capillaries (OR = 1.58, 95%CI[1.49, 1.68], I  = 0%) might increase the risk of HF. HF might increase the risk of myocardial infarction (OR = 2, 95%CI[1.17, 3.41], I  = 97%) and CVD-related death (OR = 1.78, 95%CI[1.05, 3.02], I  = 50%). Subgroup analyses showed that among Asians IHD might not raise the risk of HF (OR = 1.33, 95% CI [1.00, 1.78], I  = 95%). In caucasians, IHD might also not raise HF risk (OR = 1.52, 95%CI [0.64, 4.56], I  = 95%). This study supports possible bidirectional associations between CVD and HF, but more mechanistic studies of CVD and HF were warranted. However, high heterogeneity and potential confounding by unmeasured variables warrant cautious interpretation.
AbstractList The aim of this study was to comprehensively analyze the bidirectional association between cardiovascular disease (CVD) and hip fracture (HF).BACKGROUNDThe aim of this study was to comprehensively analyze the bidirectional association between cardiovascular disease (CVD) and hip fracture (HF).We searched PubMed, EMBASE, Web of Sciences, Cochrane Library, ScienceDirect and China National Knowledge Infrastructure for relevant studies. The Newcastle-Ottawa scale was used to evaluate the risk of bias. We conducted random effects model for meta-analysis and subgroup analysis of different ethnic groups. Sensitivity analysis and publication bias of this study were also evaluated. This study followed the PRISMA and MOOSE guidelines for systematic reviews and meta-analyses.METHODSWe searched PubMed, EMBASE, Web of Sciences, Cochrane Library, ScienceDirect and China National Knowledge Infrastructure for relevant studies. The Newcastle-Ottawa scale was used to evaluate the risk of bias. We conducted random effects model for meta-analysis and subgroup analysis of different ethnic groups. Sensitivity analysis and publication bias of this study were also evaluated. This study followed the PRISMA and MOOSE guidelines for systematic reviews and meta-analyses.This research included 18 cohort studies and case-control studies with a total sample of 1,854,441 individuals. The results showed ischemic heart disease might increase the risk of HF (OR = 1.41, 95%CI[1.05, 1.89], I2 = 96%). Stroke might be a risk factor for HF (OR = 2.23, 95%[1.18, 4.19], I2 = 97%), and HF might likewise be a risk factor for Stroke ( OR = 2.22, 95% CI [1.81, 2.71], I2 = 78%). Heart failure might increase the risk of HF (OR = 2.89, 95%CI [1.22, 6.85], I2 = 91%), and HF might increase the risk of heart failure (OR = 2.74, 95%CI [1.27, 5.89], I2 = 92%). Hypertension might increase the risk of HF (OR = 1.55, 95%CI[1.34, 1.8], I2 = 87%), and HF might increase the risk of hypertension (OR = 3.75, 95%CI[3.3, 4.26], I2 = 98%). Cerebrovascular disease (OR = 1.96, 95%CI[1.61, 2.4], I2 = 79%) and diseases of arteries, arterioles, and capillaries (OR = 1.58, 95%CI[1.49, 1.68], I2 = 0%) might increase the risk of HF. HF might increase the risk of myocardial infarction (OR = 2, 95%CI[1.17, 3.41], I2 = 97%) and CVD-related death (OR = 1.78, 95%CI[1.05, 3.02], I2 = 50%). Subgroup analyses showed that among Asians IHD might not raise the risk of HF (OR = 1.33, 95% CI [1.00, 1.78], I2 = 95%). In caucasians, IHD might also not raise HF risk (OR = 1.52, 95%CI [0.64, 4.56], I2 = 95%).RESULTSThis research included 18 cohort studies and case-control studies with a total sample of 1,854,441 individuals. The results showed ischemic heart disease might increase the risk of HF (OR = 1.41, 95%CI[1.05, 1.89], I2 = 96%). Stroke might be a risk factor for HF (OR = 2.23, 95%[1.18, 4.19], I2 = 97%), and HF might likewise be a risk factor for Stroke ( OR = 2.22, 95% CI [1.81, 2.71], I2 = 78%). Heart failure might increase the risk of HF (OR = 2.89, 95%CI [1.22, 6.85], I2 = 91%), and HF might increase the risk of heart failure (OR = 2.74, 95%CI [1.27, 5.89], I2 = 92%). Hypertension might increase the risk of HF (OR = 1.55, 95%CI[1.34, 1.8], I2 = 87%), and HF might increase the risk of hypertension (OR = 3.75, 95%CI[3.3, 4.26], I2 = 98%). Cerebrovascular disease (OR = 1.96, 95%CI[1.61, 2.4], I2 = 79%) and diseases of arteries, arterioles, and capillaries (OR = 1.58, 95%CI[1.49, 1.68], I2 = 0%) might increase the risk of HF. HF might increase the risk of myocardial infarction (OR = 2, 95%CI[1.17, 3.41], I2 = 97%) and CVD-related death (OR = 1.78, 95%CI[1.05, 3.02], I2 = 50%). Subgroup analyses showed that among Asians IHD might not raise the risk of HF (OR = 1.33, 95% CI [1.00, 1.78], I2 = 95%). In caucasians, IHD might also not raise HF risk (OR = 1.52, 95%CI [0.64, 4.56], I2 = 95%).This study supports possible bidirectional associations between CVD and HF, but more mechanistic studies of CVD and HF were warranted. However, high heterogeneity and potential confounding by unmeasured variables warrant cautious interpretation.CONCLUSIONSThis study supports possible bidirectional associations between CVD and HF, but more mechanistic studies of CVD and HF were warranted. However, high heterogeneity and potential confounding by unmeasured variables warrant cautious interpretation.
Abstract Background The aim of this study was to comprehensively analyze the bidirectional association between cardiovascular disease (CVD) and hip fracture (HF). Methods We searched PubMed, EMBASE, Web of Sciences, Cochrane Library, ScienceDirect and China National Knowledge Infrastructure for relevant studies. The Newcastle-Ottawa scale was used to evaluate the risk of bias. We conducted random effects model for meta-analysis and subgroup analysis of different ethnic groups. Sensitivity analysis and publication bias of this study were also evaluated. This study followed the PRISMA and MOOSE guidelines for systematic reviews and meta-analyses. Results This research included 18 cohort studies and case-control studies with a total sample of 1,854,441 individuals. The results showed ischemic heart disease might increase the risk of HF (OR = 1.41, 95%CI[1.05, 1.89], I 2  = 96%). Stroke might be a risk factor for HF (OR = 2.23, 95%[1.18, 4.19], I 2  = 97%), and HF might likewise be a risk factor for Stroke ( OR = 2.22, 95% CI [1.81, 2.71], I 2  = 78%). Heart failure might increase the risk of HF (OR = 2.89, 95%CI [1.22, 6.85], I 2  = 91%), and HF might increase the risk of heart failure (OR = 2.74, 95%CI [1.27, 5.89], I 2  = 92%). Hypertension might increase the risk of HF (OR = 1.55, 95%CI[1.34, 1.8], I 2  = 87%), and HF might increase the risk of hypertension (OR = 3.75, 95%CI[3.3, 4.26], I 2  = 98%). Cerebrovascular disease (OR = 1.96, 95%CI[1.61, 2.4], I 2  = 79%) and diseases of arteries, arterioles, and capillaries (OR = 1.58, 95%CI[1.49, 1.68], I 2  = 0%) might increase the risk of HF. HF might increase the risk of myocardial infarction (OR = 2, 95%CI[1.17, 3.41], I 2  = 97%) and CVD-related death (OR = 1.78, 95%CI[1.05, 3.02], I 2  = 50%). Subgroup analyses showed that among Asians IHD might not raise the risk of HF (OR = 1.33, 95% CI [1.00, 1.78], I 2  = 95%). In caucasians, IHD might also not raise HF risk (OR = 1.52, 95%CI [0.64, 4.56], I 2  = 95%). Conclusions This study supports possible bidirectional associations between CVD and HF, but more mechanistic studies of CVD and HF were warranted. However, high heterogeneity and potential confounding by unmeasured variables warrant cautious interpretation.
BackgroundThe aim of this study was to comprehensively analyze the bidirectional association between cardiovascular disease (CVD) and hip fracture (HF).MethodsWe searched PubMed, EMBASE, Web of Sciences, Cochrane Library, ScienceDirect and China National Knowledge Infrastructure for relevant studies. The Newcastle-Ottawa scale was used to evaluate the risk of bias. We conducted random effects model for meta-analysis and subgroup analysis of different ethnic groups. Sensitivity analysis and publication bias of this study were also evaluated. This study followed the PRISMA and MOOSE guidelines for systematic reviews and meta-analyses.ResultsThis research included 18 cohort studies and case-control studies with a total sample of 1,854,441 individuals. The results showed ischemic heart disease might increase the risk of HF (OR = 1.41, 95%CI[1.05, 1.89], I2 = 96%). Stroke might be a risk factor for HF (OR = 2.23, 95%[1.18, 4.19], I2 = 97%), and HF might likewise be a risk factor for Stroke ( OR = 2.22, 95% CI [1.81, 2.71], I2 = 78%). Heart failure might increase the risk of HF (OR = 2.89, 95%CI [1.22, 6.85], I2 = 91%), and HF might increase the risk of heart failure (OR = 2.74, 95%CI [1.27, 5.89], I2 = 92%). Hypertension might increase the risk of HF (OR = 1.55, 95%CI[1.34, 1.8], I2 = 87%), and HF might increase the risk of hypertension (OR = 3.75, 95%CI[3.3, 4.26], I2 = 98%). Cerebrovascular disease (OR = 1.96, 95%CI[1.61, 2.4], I2 = 79%) and diseases of arteries, arterioles, and capillaries (OR = 1.58, 95%CI[1.49, 1.68], I2 = 0%) might increase the risk of HF. HF might increase the risk of myocardial infarction (OR = 2, 95%CI[1.17, 3.41], I2 = 97%) and CVD-related death (OR = 1.78, 95%CI[1.05, 3.02], I2 = 50%). Subgroup analyses showed that among Asians IHD might not raise the risk of HF (OR = 1.33, 95% CI [1.00, 1.78], I2 = 95%). In caucasians, IHD might also not raise HF risk (OR = 1.52, 95%CI [0.64, 4.56], I2 = 95%).ConclusionsThis study supports possible bidirectional associations between CVD and HF, but more mechanistic studies of CVD and HF were warranted. However, high heterogeneity and potential confounding by unmeasured variables warrant cautious interpretation.
The aim of this study was to comprehensively analyze the bidirectional association between cardiovascular disease (CVD) and hip fracture (HF). We searched PubMed, EMBASE, Web of Sciences, Cochrane Library, ScienceDirect and China National Knowledge Infrastructure for relevant studies. The Newcastle-Ottawa scale was used to evaluate the risk of bias. We conducted random effects model for meta-analysis and subgroup analysis of different ethnic groups. Sensitivity analysis and publication bias of this study were also evaluated. This study followed the PRISMA and MOOSE guidelines for systematic reviews and meta-analyses. This research included 18 cohort studies and case-control studies with a total sample of 1,854,441 individuals. The results showed ischemic heart disease might increase the risk of HF (OR = 1.41, 95%CI[1.05, 1.89], I  = 96%). Stroke might be a risk factor for HF (OR = 2.23, 95%[1.18, 4.19], I  = 97%), and HF might likewise be a risk factor for Stroke ( OR = 2.22, 95% CI [1.81, 2.71], I  = 78%). Heart failure might increase the risk of HF (OR = 2.89, 95%CI [1.22, 6.85], I  = 91%), and HF might increase the risk of heart failure (OR = 2.74, 95%CI [1.27, 5.89], I  = 92%). Hypertension might increase the risk of HF (OR = 1.55, 95%CI[1.34, 1.8], I  = 87%), and HF might increase the risk of hypertension (OR = 3.75, 95%CI[3.3, 4.26], I  = 98%). Cerebrovascular disease (OR = 1.96, 95%CI[1.61, 2.4], I  = 79%) and diseases of arteries, arterioles, and capillaries (OR = 1.58, 95%CI[1.49, 1.68], I  = 0%) might increase the risk of HF. HF might increase the risk of myocardial infarction (OR = 2, 95%CI[1.17, 3.41], I  = 97%) and CVD-related death (OR = 1.78, 95%CI[1.05, 3.02], I  = 50%). Subgroup analyses showed that among Asians IHD might not raise the risk of HF (OR = 1.33, 95% CI [1.00, 1.78], I  = 95%). In caucasians, IHD might also not raise HF risk (OR = 1.52, 95%CI [0.64, 4.56], I  = 95%). This study supports possible bidirectional associations between CVD and HF, but more mechanistic studies of CVD and HF were warranted. However, high heterogeneity and potential confounding by unmeasured variables warrant cautious interpretation.
ArticleNumber 366
Author Wang, Junwen
Wu, Jinyi
Jiang, Qingwu
Zhou, Yibiao
Zhang, Yan
Zhang, Qingsong
Jiang, Jun
Author_xml – sequence: 1
  givenname: Jinyi
  surname: Wu
  fullname: Wu, Jinyi
– sequence: 2
  givenname: Yan
  surname: Zhang
  fullname: Zhang, Yan
– sequence: 3
  givenname: Junwen
  surname: Wang
  fullname: Wang, Junwen
– sequence: 4
  givenname: Qingsong
  surname: Zhang
  fullname: Zhang, Qingsong
– sequence: 5
  givenname: Jun
  surname: Jiang
  fullname: Jiang, Jun
– sequence: 6
  givenname: Qingwu
  surname: Jiang
  fullname: Jiang, Qingwu
– sequence: 7
  givenname: Yibiao
  surname: Zhou
  fullname: Zhou, Yibiao
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40369408$$D View this record in MEDLINE/PubMed
BookMark eNpdkktv1DAURi1URB_0D7BAlth0E_AzcdggqHhUqsQG1taNfdN6lMSDnUw1_76embZqWfl1fPzJ956SoylOSMg7zj5ybupPmQvTiIoJXTFlhKzUK3LCVcMrIWp-9Gx-TE5zXjHGG8PaN-RYMVm3ipkTsv4WfEjo5hAnGCjkHF2A3Yp2ON8hTtRB8iFuILtlgER9yAgZKUye3oY17RO4eUn4mQLN2zzjWK47mnAT8G5PjThDBUW_zSG_Ja97GDKeP4xn5O-P738uf1XXv39eXX69rpzSbK5k3YAELbkUSjoUrjZ1p3nXsR6N7rhRYAB7rbxBV2NjnBe8NV43WjbK1fKMXB28PsLKrlMYIW1thGD3GzHdWEgl6IAWmG7bpivvmF41Xna9Vx6g5RJrrYUrri8H13rpRvQOpznB8EL68mQKt_YmbiwXzDDBVTFcPBhS_Ldgnu0YssNhgAnjkq0UTEnJmdEF_fAfuopLKr-3o3gJVEooCvX-eaSnLI-VLYA4AC7FnBP2Twhndtc-9tA-trSP3bePVfIeMW-5Cw
Cites_doi 10.1007/s00198-015-3097-y
10.1007/s00296-023-05492-2
10.3390/ijms242015485
10.1016/j.amjmed.2012.06.032
10.1016/j.jamda.2015.08.022
10.1007/s11657-020-00792-7
10.1155/2013/493696
10.1155/2022/2786147
10.1111/bcp.14799
10.1002/jbmr.3089
10.1093/eurheartj/ehp483
10.1093/ageing/afu009
10.2188/jea.JE20120071
10.1210/jc.2011-3055
10.1007/s00198-007-0386-0
10.1007/s00198-018-4611-9
10.1016/j.ijcard.2017.05.012
10.1007/s00198-019-05042-2
10.1001/jama.2009.1463
10.1007/s11657-017-0376-6
10.3390/nano11051238
10.1161/CIRCULATIONAHA.108.784009
10.1002/jbmr.3242
10.1002/jcsm.12516
10.1002/jbmr.3448
10.1359/jbmr.091029
10.1302/0301-620X.98B4.37201
10.1007/s00198-016-3616-5
10.1111/brv.12721
10.1007/s00198-012-2218-0
10.1016/j.cbpc.2023.109741
10.1161/STROKEAHA.110.595538
10.1007/s11548-023-03017-7
10.1016/j.amjmed.2010.11.029
10.1016/j.jns.2021.117512
10.1007/s00198-017-4192-z
10.1136/bmj.n265
10.3390/jcm8070932
10.1038/nrcardio.2016.105
10.1007/s00198-019-05056-w
10.1016/j.intimp.2022.109207
10.1038/nrrheum.2011.75
10.1002/jbmr.1714
10.1161/STROKEAHA.109.554055
10.3390/jcm9020429
10.1016/j.afos.2022.03.003
10.1007/s00223-010-9431-7
10.1007/s00223-016-0194-7
10.1093/sxmrev/qead031
ContentType Journal Article
Copyright 2025. The Author(s).
2025. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2025 2025
Copyright_xml – notice: 2025. The Author(s).
– notice: 2025. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2025 2025
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QP
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
COVID
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
7X8
5PM
DOA
DOI 10.1186/s12872-025-04823-4
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Calcium & Calcified Tissue Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
Coronavirus Research Database
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
Coronavirus Research Database
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

Publicly Available Content Database
MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Open Access Full Text
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1471-2261
EndPage 10
ExternalDocumentID oai_doaj_org_article_a05997b43c8f47d3bfd4daa913e6552c
PMC12080214
40369408
10_1186_s12872_025_04823_4
Genre Meta-Analysis
Systematic Review
Journal Article
GrantInformation_xml – fundername: The Three-year (2023-2025) Action Plan of Shanghai Public Health System Development.
  grantid: GWVI-11.2-YQ18
GroupedDBID ---
0R~
23N
2WC
53G
5VS
6J9
6PF
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
AAYXX
ABUWG
ACGFO
ACGFS
ACIHN
ACPRK
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EBD
EBLON
EBS
ECGQY
EMB
EMOBN
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KQ8
M1P
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
UKHRP
W2D
WOQ
WOW
XSB
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
3V.
7QP
7XB
8FK
AZQEC
COVID
DWQXO
K9.
M48
PKEHL
PQEST
PQUKI
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c450t-367a3a5313243ce2c686b51bb0fe85b184a8aef54d8ec6e78cd2198d575374c63
IEDL.DBID DOA
ISSN 1471-2261
IngestDate Wed Aug 27 01:25:34 EDT 2025
Thu Aug 21 18:31:30 EDT 2025
Fri Jul 11 17:54:46 EDT 2025
Fri Jul 25 09:51:25 EDT 2025
Mon Jul 21 06:03:04 EDT 2025
Tue Jul 01 04:58:22 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords CVD
Risk
Systematic review
Hip fracture
Meta-analysis
Language English
License 2025. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c450t-367a3a5313243ce2c686b51bb0fe85b184a8aef54d8ec6e78cd2198d575374c63
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Undefined-1
ObjectType-Feature-3
content type line 23
OpenAccessLink https://doaj.org/article/a05997b43c8f47d3bfd4daa913e6552c
PMID 40369408
PQID 3216558092
PQPubID 44077
PageCount 10
ParticipantIDs doaj_primary_oai_doaj_org_article_a05997b43c8f47d3bfd4daa913e6552c
pubmedcentral_primary_oai_pubmedcentral_nih_gov_12080214
proquest_miscellaneous_3204331085
proquest_journals_3216558092
pubmed_primary_40369408
crossref_primary_10_1186_s12872_025_04823_4
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2025-05-15
PublicationDateYYYYMMDD 2025-05-15
PublicationDate_xml – month: 05
  year: 2025
  text: 2025-05-15
  day: 15
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle BMC cardiovascular disorders
PublicationTitleAlternate BMC Cardiovasc Disord
PublicationYear 2025
Publisher BioMed Central
BMC
Publisher_xml – name: BioMed Central
– name: BMC
References 4823_CR51
4823_CR50
G Loncar (4823_CR7) 2020; 11
4823_CR53
4823_CR52
4823_CR11
JI Barzilay (4823_CR38) 2018; 29
CW Sing (4823_CR9) 2018; 33
M von Friesendorff (4823_CR30) 2016; 27
AB Pedersen (4823_CR25) 2017; 32
G Ge (4823_CR35) 2019; 30
JH Kang (4823_CR23) 2011; 42
JS Chen (4823_CR41) 2011; 88
R Khatib (4823_CR36) 2014; 43
KK Kim (4823_CR3) 2022; 8
YMDDSCC Zhang (4823_CR33) 2021; 42
L Carbone (4823_CR18) 2010; 31
B Leavy (4823_CR39) 2017; 100
FC Luft (4823_CR5) 2016; 13
J Park (4823_CR45) 2023; 273
Z Hyde (4823_CR22) 2013; 24
CX Wong (4823_CR31) 2017; 243
SR Majumdar (4823_CR8) 2012; 97
YMALJTCLLZLZP Tang (4823_CR16) 2015; 17
ID Cameron (4823_CR17) 2010; 25
U Sennerby (4823_CR27) 2007; 18
E Montane (4823_CR13) 2021; 87
S Pouwels (4823_CR26) 2009; 40
B Xu (4823_CR32) 2013; 2013
HBJZHHT Sun (4823_CR34) 2019; 8
D Norring-Agerskov (4823_CR47) 2019; 30
Y Gerber (4823_CR21) 2011; 124
N Veronese (4823_CR14) 2017; 32
S van Diepen (4823_CR37) 2008; 118
FL Liu (4823_CR24) 2017; 28
S Jansen (4823_CR49) 2016; 17
O Lesnyak (4823_CR4) 2020; 15
KMYCHWPCJ He (4823_CR15) 2015; 10
P Huang (4823_CR43) 2022; 2022
U Sennerby (4823_CR28) 2009; 302
MP Abdel (4823_CR1) 2016; 98–B
R Mazzucchelli Esteban (4823_CR2) 2017; 12
4823_CR42
Y Gerber (4823_CR20) 2013; 126
AM Traish (4823_CR44) 2023; 11
HP Wang (4823_CR10) 2021; 427
4823_CR46
4823_CR48
CH Chiang (4823_CR19) 2013; 28
RE O’Dea (4823_CR12) 2021; 96
CH Tsai (4823_CR29) 2015; 26
SW Lai (4823_CR40) 2013; 23
DP Symmons (4823_CR6) 2011; 7
References_xml – volume: 17
  start-page: 740
  issue: 9
  year: 2015
  ident: 4823_CR16
  publication-title: Chin J Orthop Trauma
– volume: 26
  start-page: 1849
  issue: 6
  year: 2015
  ident: 4823_CR29
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-015-3097-y
– ident: 4823_CR51
  doi: 10.1007/s00296-023-05492-2
– ident: 4823_CR42
  doi: 10.3390/ijms242015485
– volume: 126
  start-page: e16919
  issue: 2
  year: 2013
  ident: 4823_CR20
  publication-title: Am J Med
  doi: 10.1016/j.amjmed.2012.06.032
– volume: 17
  start-page: 193
  issue: 3
  year: 2016
  ident: 4823_CR49
  publication-title: J Am Med Dir Assoc
  doi: 10.1016/j.jamda.2015.08.022
– volume: 15
  start-page: 119
  issue: 1
  year: 2020
  ident: 4823_CR4
  publication-title: Arch Osteoporos
  doi: 10.1007/s11657-020-00792-7
– volume: 2013
  start-page: 493696
  year: 2013
  ident: 4823_CR32
  publication-title: Biomed Res Int
  doi: 10.1155/2013/493696
– volume: 2022
  start-page: 2786147
  year: 2022
  ident: 4823_CR43
  publication-title: Biomed Res Int
  doi: 10.1155/2022/2786147
– volume: 87
  start-page: 3659
  issue: 10
  year: 2021
  ident: 4823_CR13
  publication-title: Br J Clin Pharmacol
  doi: 10.1111/bcp.14799
– volume: 32
  start-page: 1126
  issue: 5
  year: 2017
  ident: 4823_CR14
  publication-title: J Bone Min Res
  doi: 10.1002/jbmr.3089
– volume: 31
  start-page: 77
  issue: 1
  year: 2010
  ident: 4823_CR18
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehp483
– volume: 43
  start-page: 629
  issue: 5
  year: 2014
  ident: 4823_CR36
  publication-title: Age Ageing
  doi: 10.1093/ageing/afu009
– volume: 23
  start-page: 109
  issue: 2
  year: 2013
  ident: 4823_CR40
  publication-title: J Epidemiol
  doi: 10.2188/jea.JE20120071
– volume: 97
  start-page: 1179
  issue: 4
  year: 2012
  ident: 4823_CR8
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2011-3055
– volume: 18
  start-page: 1355
  issue: 10
  year: 2007
  ident: 4823_CR27
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-007-0386-0
– volume: 29
  start-page: 2219
  issue: 10
  year: 2018
  ident: 4823_CR38
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-018-4611-9
– volume: 243
  start-page: 229
  year: 2017
  ident: 4823_CR31
  publication-title: Int J Cardiol
  doi: 10.1016/j.ijcard.2017.05.012
– volume: 30
  start-page: 1903
  issue: 10
  year: 2019
  ident: 4823_CR35
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-019-05042-2
– volume: 302
  start-page: 1666
  issue: 15
  year: 2009
  ident: 4823_CR28
  publication-title: JAMA
  doi: 10.1001/jama.2009.1463
– volume: 42
  start-page: 49
  issue: 1
  year: 2021
  ident: 4823_CR33
  publication-title: Int J Orthop
– volume: 12
  start-page: 84
  issue: 1
  year: 2017
  ident: 4823_CR2
  publication-title: Arch Osteoporos
  doi: 10.1007/s11657-017-0376-6
– ident: 4823_CR53
  doi: 10.3390/nano11051238
– volume: 118
  start-page: 1946
  issue: 19
  year: 2008
  ident: 4823_CR37
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.108.784009
– volume: 32
  start-page: 2339
  issue: 12
  year: 2017
  ident: 4823_CR25
  publication-title: J Bone Min Res
  doi: 10.1002/jbmr.3242
– volume: 8
  start-page: 201
  issue: 3
  year: 2019
  ident: 4823_CR34
  publication-title: Chin J Bone Joint
– volume: 11
  start-page: 381
  issue: 2
  year: 2020
  ident: 4823_CR7
  publication-title: J Cachexia Sarcopenia Muscle
  doi: 10.1002/jcsm.12516
– volume: 33
  start-page: 1422
  issue: 8
  year: 2018
  ident: 4823_CR9
  publication-title: J Bone Min Res
  doi: 10.1002/jbmr.3448
– volume: 25
  start-page: 866
  issue: 4
  year: 2010
  ident: 4823_CR17
  publication-title: J Bone Min Res
  doi: 10.1359/jbmr.091029
– volume: 98–B
  start-page: 461
  issue: 4
  year: 2016
  ident: 4823_CR1
  publication-title: Bone Joint J
  doi: 10.1302/0301-620X.98B4.37201
– volume: 27
  start-page: 2945
  issue: 10
  year: 2016
  ident: 4823_CR30
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-016-3616-5
– volume: 96
  start-page: 1695
  issue: 5
  year: 2021
  ident: 4823_CR12
  publication-title: Biol Rev Camb Philos Soc
  doi: 10.1111/brv.12721
– volume: 24
  start-page: 1683
  issue: 5
  year: 2013
  ident: 4823_CR22
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-012-2218-0
– volume: 273
  start-page: 109741
  year: 2023
  ident: 4823_CR45
  publication-title: Comp Biochem Physiol C Toxicol Pharmacol
  doi: 10.1016/j.cbpc.2023.109741
– volume: 42
  start-page: 336
  issue: 2
  year: 2011
  ident: 4823_CR23
  publication-title: Stroke
  doi: 10.1161/STROKEAHA.110.595538
– ident: 4823_CR48
  doi: 10.1007/s11548-023-03017-7
– volume: 124
  start-page: 418
  issue: 5
  year: 2011
  ident: 4823_CR21
  publication-title: Am J Med
  doi: 10.1016/j.amjmed.2010.11.029
– volume: 427
  start-page: 117512
  year: 2021
  ident: 4823_CR10
  publication-title: J Neurol Sci
  doi: 10.1016/j.jns.2021.117512
– volume: 28
  start-page: 3123
  issue: 11
  year: 2017
  ident: 4823_CR24
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-017-4192-z
– ident: 4823_CR11
  doi: 10.1136/bmj.n265
– ident: 4823_CR52
  doi: 10.3390/jcm8070932
– volume: 13
  start-page: 445
  issue: 8
  year: 2016
  ident: 4823_CR5
  publication-title: Nat Rev Cardiol
  doi: 10.1038/nrcardio.2016.105
– volume: 30
  start-page: 1767
  issue: 9
  year: 2019
  ident: 4823_CR47
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-019-05056-w
– volume: 10
  start-page: 1746
  issue: 12
  year: 2015
  ident: 4823_CR15
  publication-title: China Med
– ident: 4823_CR46
  doi: 10.1016/j.intimp.2022.109207
– volume: 7
  start-page: 399
  issue: 7
  year: 2011
  ident: 4823_CR6
  publication-title: Nat Rev Rheumatol
  doi: 10.1038/nrrheum.2011.75
– volume: 28
  start-page: 404
  issue: 2
  year: 2013
  ident: 4823_CR19
  publication-title: J Bone Min Res
  doi: 10.1002/jbmr.1714
– volume: 40
  start-page: 3281
  issue: 10
  year: 2009
  ident: 4823_CR26
  publication-title: Stroke
  doi: 10.1161/STROKEAHA.109.554055
– ident: 4823_CR50
  doi: 10.3390/jcm9020429
– volume: 8
  start-page: 17
  issue: 1
  year: 2022
  ident: 4823_CR3
  publication-title: Osteoporos Sarcopenia
  doi: 10.1016/j.afos.2022.03.003
– volume: 88
  start-page: 9
  issue: 1
  year: 2011
  ident: 4823_CR41
  publication-title: Calcif Tissue Int
  doi: 10.1007/s00223-010-9431-7
– volume: 100
  start-page: 1
  issue: 1
  year: 2017
  ident: 4823_CR39
  publication-title: Calcif Tissue Int
  doi: 10.1007/s00223-016-0194-7
– volume: 11
  start-page: 384
  issue: 4
  year: 2023
  ident: 4823_CR44
  publication-title: Sex Med Rev
  doi: 10.1093/sxmrev/qead031
SSID ssj0017809
Score 2.3779356
SecondaryResourceType review_article
Snippet The aim of this study was to comprehensively analyze the bidirectional association between cardiovascular disease (CVD) and hip fracture (HF). We searched...
BackgroundThe aim of this study was to comprehensively analyze the bidirectional association between cardiovascular disease (CVD) and hip fracture...
The aim of this study was to comprehensively analyze the bidirectional association between cardiovascular disease (CVD) and hip fracture (HF).BACKGROUNDThe aim...
Abstract Background The aim of this study was to comprehensively analyze the bidirectional association between cardiovascular disease (CVD) and hip fracture...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 366
SubjectTerms Aged
Aged, 80 and over
Arteries
Arterioles
Blood vessels
Capillaries
Cardiovascular disease
Cardiovascular diseases
Cardiovascular Diseases - diagnosis
Cardiovascular Diseases - epidemiology
Cerebral infarction
Cerebrovascular diseases
Congestive heart failure
Cross-sectional studies
CVD
Ethnicity
Female
Fractures
Heart Disease Risk Factors
Heart diseases
Heart failure
Heart Failure - diagnosis
Heart Failure - epidemiology
Hip
Hip fracture
Hip Fractures - diagnosis
Hip Fractures - epidemiology
Hip Fractures - ethnology
Hip joint
Humans
Hypertension
Ischemia
Male
Meta-analysis
Middle Aged
Minority & ethnic groups
Mortality
Myocardial infarction
Observational studies
Prognosis
Risk
Risk Assessment
Risk Factors
Sensitivity analysis
Stroke
Stroke - diagnosis
Stroke - epidemiology
Systematic Review
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LixQxEA66gngR37auEsGbhO3uPMeLuOKyCOvJhbmFPN052DM7j_9vVTozY4t47a5DJfVIVaXqCyHvMwTFPOfMAiQDTAQPNmdSwpynizq2MUQsDVx9V5fX4ttczmvBbVPbKvc-sTjquAxYIz_jfaekNO2s_7S6ZfhqFN6u1ic07pJ7CF2GWq3nh4Sr00C-H5Qx6mwDvlj3DB9wBb3tOROTw6hg9v8r0Py7X_KPA-jiEXlYI0f6eRT1Y3InDU_I_at6N_6UrM4X4_lUinvUHfed1mYsGibNp7RezlA3RHqzWNGME1O7dfpIHT0iPNNxuqVQ_Upbx1zFMXlGri--_vhyyep7CiwI2W4ZV9pxJxGsUfCQ-qCM8rLzvs3JSA-5njMuZSmiSUElbUIEf2YiRHRci6D4c3IyLIf0klBhfGxnUQbE81JtdBEik34m2iyzctk05MN-Y-1qhM2wJd0wyo5isCAGW8RgRUPOce8PlAh5XT4s1z9ttSDrEElGe-DcZKEj9zmK6Nys4wkUow8NOd1LzlY73Nij1jTk3eE3WBBei7ghLXdIgyBuOIXRkBejoA-cCDjgYVWwHjNRgQmr0z_D4qagdHc9jjF34tX_-XpNHvRFIyXr5Ck52a536Q3EOVv_tijzb59w_t0
  priority: 102
  providerName: ProQuest
Title Bidirectional association between cardiovascular disease and hip fracture: a systematic review and meta-analysis
URI https://www.ncbi.nlm.nih.gov/pubmed/40369408
https://www.proquest.com/docview/3216558092
https://www.proquest.com/docview/3204331085
https://pubmed.ncbi.nlm.nih.gov/PMC12080214
https://doaj.org/article/a05997b43c8f47d3bfd4daa913e6552c
Volume 25
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LaxsxEBZtCqWX0vS5TWpU6K2I7Ort3OqQEAIJJTRgehF6Eh-yMYn9_zvSyk42FHrpZQ8rHaR5aGY0M58Q-pbAKWYpJeIhGCDcO9A5HWOOebqgQht8yFcD5xfy9IqfzcX80VNfuSZsgAceCHdgM4CIcpx5nbgKzKXAg7XTjkUpBPX59AWbtwmmav5A6Xa6aZHR8uAeTmFFSX66FSSWMsJHZqig9f_NxXxaKfnI9Jy8Qa-rz4h_DGvdRc9i_xa9PK9Z8XdoOVsMlqlc62H7QHFcy7CwH5Wd4pqWwbYP-HqxxCn3Sq3v4iG2-AHbGQ99LWXWTVxZYiuCyXt0dXL86-iU1JcUiOeiXREmlWVWZJhGIGSkXmrpROdcm6IWDqI8q21MggcdvYxK-wAnmQ7gyzHFvWQf0E5_28dPCHPtQjsNwmckL9kGG8AnoVPeJpGkTbpB3zeENcsBMMOUQENLM7DBABtMYYPhDZpl2m9nZrDr8gNEwFQRMP8SgQbtbzhnqgbeG0Y7GAQxoA36uh0G3ckJEdvH23Wek-Hbcv9Fgz4OjN6uhINph13BfvRIBEZLHY_0i-uCz93R3MDc8c__Y3N76BUtcitIJ_bRzupuHb-AH7RyE_RczdUEvZgdX_y8nBQFgO_l7PcfP0ALfg
linkProvider Directory of Open Access Journals
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIgEXxLMEChgJTshq4tiOFwkhClRb2u2plfZmHD_oHsgu-xDiT_EbGTvJLosQt15jKxp7ZuwZz8w3AC8DGsVlCIFadAYotzXqnPI--jyFq1zurItPA6MzObzgn8divAO_-lqYmFbZn4npoHZTG9_ID0pWSCFUPmDvZt9p7BoVo6t9C41WLE78zx_osi3eHn9E_r5i7OjT-Ych7boKUMtFvqSlrExpRIQs5KX1zEola1HUdR68EjV6PEYZHwR3ylvpK2UdarVyaNeUFbeyxP9eg-t48ebR2avGawevqJC8vjBHyYMFnv0Vo7FhLOoJKynfuvxSj4B_GbZ_52f-ceEd3YHbnaVK3reidRd2fHMPboy6WPx9mB1O2vswPSYSs-Ez6ZK_iN1KdiVdMIiYxpHLyYyEWKG1mvs3xJANojRpq2nSrG9-aajpcFMewMWV7PRD2G2mjX8EhKva5QMnbMQPk7kzDi0hNuB5EEGaoDJ43W-snrUwHTq5N0rqlg0a2aATGzTP4DDu_XpmhNhOH6bzr7rTWG0ick1VI-Uq8MqVdXDcGTMoSo-CyGwG-z3ndKf3C72R0gxerIdRY2MYxjR-uopzImhcrPrIYK9l9JoSjgYFrgrXo7ZEYIvU7ZFmcplQwQsWy6YL_vj_dD2Hm8Pz0ak-PT47eQK3WJJOQQuxD7vL-co_RRtrWT9Lgk3gy1Vr0m_B5zs9
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Bidirectional+association+between+cardiovascular+disease+and+hip+fracture%3A+a+systematic+review+and+meta-analysis&rft.jtitle=BMC+cardiovascular+disorders&rft.au=Wu%2C+Jinyi&rft.au=Zhang%2C+Yan&rft.au=Wang%2C+Junwen&rft.au=Zhang%2C+Qingsong&rft.date=2025-05-15&rft.issn=1471-2261&rft.eissn=1471-2261&rft.volume=25&rft.issue=1&rft.spage=366&rft_id=info:doi/10.1186%2Fs12872-025-04823-4&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2261&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2261&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2261&client=summon